The Future of Decision-Making in Colorectal Cancer: ctDNA’s Emerging Role

home / around-the-practice / the-future-of-decision-making-in-colorectal-cancer-ctdna-s-emerging-role

A panel of experts review the historically available treatment decision-making tools for patients with colorectal cancer and discuss the current and future use of minimal residual disease (MRD) and circulating tumor DNA (ctDNA) testing as it relates to key clinical trial data.